Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/UTROGESTAN 400 MG CAPSULAS VAGINALES BLANDAS

Approved

STANDARD

UTROGESTAN 400 MG CAPSULAS VAGINALES BLANDAS

Besins Healthcare Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 7, 2025
Approval ID: 4ec4403d4210908d
Company: Besins Healthcare Ireland Limited
Type: Standard

Approval Details

Approval Id: 4ec4403d4210908d
Drug Cima Aemps Name: UTROGESTAN 400 MG CAPSULAS VAGINALES BLANDAS
Register Number: 89979
Holder Company Name: Besins Healthcare Ireland Limited
Marketing Company Name: Laboratorios Rubio S.A.
Authorization Date: 2025-11-07
Dosage Form: CÁPSULA VAGINAL BLANDA
Dose: 400 mg
Route Of Administration: VÍA VAGINAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Besins Healthcare Ireland Limited

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 7, 2025

Approval ID

4ec4403d4210908d

Type

Standard

Back to CIMA-AEMPS Approvals

UTROGESTAN 400 MG CAPSULAS VAGINALES BLANDAS - CIMA-AEMPS Drug Approval Details